A doctor at the University of South Carolina submitted a petition to the U.S. Food and Drug Administration (FDA) seeking that the Black Box warning for the antibiotic drug Levaquin be updated to reflect the risk for a neurological disorder called Mitochondrial Toxicity. The Black Box warning already includes information on tendon rupture.
Dr. Charles Bennett submitted the petition after reading a report written by the FDA in 2013 about Mitochondrial Toxicity. This report has not been released, and was acquired through use of the Freedom of Information Act, according to a press release from the Quinolone Vigilance Foundation.
The FDA report draws a link between drugs containing fluoroquinolone, such as Levaquin, and incidences of Mitochondrial Toxicity that lead to Parkinson’s, Alzheimer’s, and ALS.
As the many sufferers of Levaquin injuries understand, this antibiotic poses serious health risks to its consumers. Therefore, if Levaquin is the cause of Mitochondrial Toxicity, it is of the utmost importance to educate patients and health care providers about this serious drug side effect through updating the Levaquin Black Box warning.
Carey Danis & Lowe represents victims in Levaquin lawsuits, and through hearing the devastating stories of our clients, we have a deep understanding of the importance of drug warnings.
Carey Danis & Lowe, Advocates of Levaquin Victims
A St. Louis law firm that practices defective drug litigation, Carey Danis & Lowe represents individuals who have been injured by Levaquin. Our attorneys are currently investigating Levaquin cases, and are available to discuss legal options and compensation eligibility with those who believe that they have been injured after using Levaquin.
Carey Danis & Lowe offers free initial case evaluations.
If you have been harmed by Levaquin, we encourage you to share your Levaquin story with one of our defective drug lawyers today. You can reach our law firm by phone at 800.721.2519, or by completing our confidential personal injury claim form.
We look forward to assisting you in any way that we can.References: Levaquin, Pharmaceutical litigation